Serologic profile of myasthenia gravis and distinction from the Lambert- Eaton myasthenic syndrome

Neurology

Volumn 48, Issue 4 SUPPL. 5, 1997, Pages

  Lennon, Vanda A ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL AFFECTING AGENT; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY;

ANTIBODY DETECTION; ANTIGEN BINDING; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; EATON LAMBERT SYNDROME; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MYASTHENIA GRAVIS; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECEPTOR BINDING; SERODIAGNOSIS;

EID: 0030907731     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.suppl_5.23s     Document Type: Conference Paper

References (18)

1. Howard FM Jr, Lennon VA, Finley J, Matsumoto J, Elveback LR. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann NY Acad Sci 1987;505:526-538.
2. Griesmann GE, Lennon VA. Detection of autoantibodies in myasthenia gravis and Lambert-Eaton myasthenic syndrome. In: Rose NR, Conway DeMacario E, Folds JD, Lane HC, Nakamaura RM, eds. Manual of clinical and laboratory immunology, 5th ed. ASM Press: Washington, DC, 1997:983-988.
3. Beeson D, Amar M, Bermudez I, Vincent A, Newsom-Davis J. Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the ∈ subunit. Neurosci Lett 1996;207:57-60.
4. Beeson D, Vincent A, Newsom-Davis J. A transfected cell line expressing the human acetylcholine receptor epsilon subunit for diagnostic assays in myasthenia gravis [abstract]. Neurology 1996;46(suppl):A333.
5. Sundevall AC, Lefvert AK, Olsson R. Anti-acetylcholine receptor antibodies in primary biliary cirrhosis. Acta Med Scand 1985;217:519-525.
6. Hay JE, Lennon VA, Czaja AJ, LaRusso NF, Dickson ER. High frequency of acetylcholine receptor binding antibodies in autoimmune liver diseases [abstract]. Clin Res 1989;37: 538A.
7. Lennon VA. Serological diagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. In: Lisak R, ed. Handbook of myasthenia gravis. New York: Marcel Dekker, 1994:149-164.
8. Lennon VA, Howard FM. Serological diagnosis of myasthenia gravis. In: Nakamura RM, O'Sullivan MB, eds. Clinical laboratory molecular analysis: new strategies in autoimmunity, cancer and virology. New York: Grune & Stratton, 1985:29-44.
9. Rosenow EC, Hurley BT. Disorders of the thymus. A review. Arch Intern Med 1984;144:763-770.
10. Cikes N, Momoi MY, Williams CL, et al. Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma and recipients of D-penicillamine and allogeneic bone marrow. Mayo Clin Proc 1988;63:474-481.
11. Lennon VA, Lambert EH, Whittingham S, Fairbanks V. Autoimmunity in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1982;5:S21-S25.
12. Garlepp MJ, Dawkins RL, Christiansen FT, et al. Autoimmunity in ocular and generalized myasthenia gravis. J Neuroimmunol 1981;1:325-332.
13. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in Lambert-Eaton myasthenic syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332: 1467-1474.
14. Lennon VA, Lambert EH. Autoantibodies bind solubilized calcium channel-ω-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc 1989;64:1498-1504.
15. Sano M, Lambert EH, McCormick DJ, Lennon VA. Muscle acetylcholine receptors complexed with autologous IgG reflect seropositivity but not necessarily in vivo binding. Neurology 1992;42:218-222.
16. Lennon VA. Calcium channel and related paraneoplastic disease autoantibodies. In: Peter JB, Schoenfeld Y, eds. Textbook of autoantibodies. Amsterdam: Elsevier Science Publishers, 1996:139-147.
17. Retzlaff JA, Kearns TP, Howard FM Jr, Cronin ML. Lancaster red-green test in evaluation of edrophonium effect in myasthenia gravis. Am J Ophthalmol 1969;67:13-21.
18. Engel AG. Myasthenic syndromes. In: Engel AG, Franzini-Armstrong C, eds. Myology, 2nd ed. New York: McGraw-Hill, 1994:1798-1835.